- Home
- ITIC vs CKPT Comparison
ITIC vs CKPT Comparison
Compare ITIC & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- CKPT
- Stock Information
- Founded
- ITIC 1972
- CKPT 2014
- Country
- ITIC United States
- CKPT United States
- Employees
- ITIC N/A
- CKPT N/A
- Industry
- ITIC Specialty Insurers
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- ITIC Finance
- CKPT Health Care
- Exchange
- ITIC Nasdaq
- CKPT Nasdaq
- Market Cap
- ITIC 440.1M
- CKPT 361.1M
- IPO Year
- ITIC N/A
- CKPT 2017
- Fundamental
- Price
- ITIC $195.87
- CKPT N/A
- Analyst Decision
- ITIC
- CKPT Buy
- Analyst Count
- ITIC 0
- CKPT 3
- Target Price
- ITIC N/A
- CKPT $4.33
- AVG Volume (30 Days)
- ITIC 90.6K
- CKPT 2.1M
- Earning Date
- ITIC 08-05-2025
- CKPT 05-13-2025
- Dividend Yield
- ITIC 0.94%
- CKPT N/A
- EPS Growth
- ITIC 18.56
- CKPT N/A
- EPS
- ITIC 15.69
- CKPT N/A
- Revenue
- ITIC $261,197,999.00
- CKPT $41,000.00
- Revenue This Year
- ITIC N/A
- CKPT $102,182.93
- Revenue Next Year
- ITIC N/A
- CKPT $351.71
- P/E Ratio
- ITIC $12.37
- CKPT N/A
- Revenue Growth
- ITIC 15.27
- CKPT N/A
- 52 Week Low
- ITIC $168.74
- CKPT $1.80
- 52 Week High
- ITIC $290.40
- CKPT $4.50
- Technical
- Relative Strength Index (RSI)
- ITIC 29.02
- CKPT 3.56
- Support Level
- ITIC $190.20
- CKPT $4.14
- Resistance Level
- ITIC $235.99
- CKPT $4.28
- Average True Range (ATR)
- ITIC 8.84
- CKPT 0.02
- MACD
- ITIC -5.20
- CKPT -0.52
- Stochastic Oscillator
- ITIC 9.11
- CKPT 0.00
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.